ERD

SMR Congress 2018 Abstracts

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) Zurich, Switzerland, March 7-10, 2018

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Abstract 5372: The mutational landscape of primary cutaneous melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Abstract 5204: MYC expression and smoking as drivers of failure of immune response to melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

ctDNA as a noninvasive monitoring tool in metastatic melanoma.

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

D5.5

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Frequent GNAQ, GNA11 , and EIF1AX Mutations in Iris Melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

PO-399 Tumour CDKN2A loss predisposes to immunotherapy resistance

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Genome-wide analysis of constitutional DNA methylation in familial melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

SMR Congress 2017 abstracts

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

PO-493 ctDNA profiles of metastatic melanoma patients under therapy

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by hi...

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Melanoma Immunotherapy: Next-Generation Biomarkers

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

MEK inhibition and immune responses in advanced melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninva...

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically...

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Assessing a single SNP located at TERT/CLPTM1L multi-cancer risk region as a genetic modifier for risk of pancreatic can...

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

NEK11 as a candidate high-penetrance melanoma susceptibility gene

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

A novel germline variant in the DOT1L gene co-segregating in a Dutch family with a history of melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Tumor genetic heterogeneity analysis of chronic sun‐damaged melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

The safety of anti PD-1 therapeutics for the treatment of melanoma

Project: MELGEN

Updated at: 28-04-2024

Show more information

Project acronym MELGEN

Resources

Selected filters:

SMR Congress 2018 Abstracts

45th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) Zurich, Switzerland, March 7-10, 2018

Abstract 5372: The mutational landscape of primary cutaneous melanoma

Abstract 5204: MYC expression and smoking as drivers of failure of immune response to melanoma

The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response

ctDNA as a noninvasive monitoring tool in metastatic melanoma.

D5.5

Frequent GNAQ, GNA11 , and EIF1AX Mutations in Iris Melanoma

Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma

PO-399 Tumour CDKN2A loss predisposes to immunotherapy resistance

Genome-wide analysis of constitutional DNA methylation in familial melanoma

SMR Congress 2017 abstracts

PO-493 ctDNA profiles of metastatic melanoma patients under therapy

Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by hi...

Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma

High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material

Melanoma Immunotherapy: Next-Generation Biomarkers

MEK inhibition and immune responses in advanced melanoma

Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninva...

Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically...

Assessing a single SNP located at TERT/CLPTM1L multi-cancer risk region as a genetic modifier for risk of pancreatic can...

Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

NEK11 as a candidate high-penetrance melanoma susceptibility gene

A novel germline variant in the DOT1L gene co-segregating in a Dutch family with a history of melanoma

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma

Tumor genetic heterogeneity analysis of chronic sun‐damaged melanoma

The safety of anti PD-1 therapeutics for the treatment of melanoma